AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $577,000 | -38.6% | 30,000 | -5.7% | 0.09% | +42.9% |
Q2 2019 | $940,000 | +6.3% | 31,800 | +71.0% | 0.06% | -26.7% |
Q1 2019 | $884,000 | +31.7% | 18,600 | 0.0% | 0.09% | -36.8% |
Q4 2018 | $671,000 | -41.4% | 18,600 | 0.0% | 0.14% | +78.9% |
Q3 2018 | $1,145,000 | -8.8% | 18,600 | 0.0% | 0.08% | -32.7% |
Q2 2018 | $1,256,000 | -7.4% | 18,600 | -25.6% | 0.11% | -13.7% |
Q1 2018 | $1,356,000 | -50.7% | 25,000 | -45.7% | 0.13% | -51.3% |
Q4 2017 | $2,749,000 | +13.6% | 46,000 | -7.6% | 0.27% | -47.3% |
Q3 2017 | $2,420,000 | -25.7% | 49,800 | -19.6% | 0.51% | -36.6% |
Q2 2017 | $3,256,000 | -15.5% | 61,959 | -27.1% | 0.80% | -30.1% |
Q1 2017 | $3,853,000 | -24.3% | 84,959 | -36.8% | 1.15% | -71.6% |
Q4 2016 | $5,091,000 | +0.3% | 134,500 | 0.0% | 4.06% | +104.8% |
Q3 2016 | $5,076,000 | +412.7% | 134,500 | +139.2% | 1.98% | +366.4% |
Q2 2016 | $990,000 | -69.9% | 56,225 | -58.4% | 0.42% | -13.6% |
Q4 2015 | $3,287,000 | +164.7% | 135,000 | +92.9% | 0.49% | -42.2% |
Q3 2015 | $1,242,000 | – | 70,000 | – | 0.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 244,783 | $1,718,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $32,959,000 | 0.69% |
DCF Advisers, LLC | 192,065 | $1,348,000 | 0.55% |
LEVIN CAPITAL STRATEGIES, L.P. | 817,377 | $5,738,000 | 0.54% |
DAFNA Capital Management LLC | 289,040 | $2,029,000 | 0.51% |
Rhenman & Partners Asset Management AB | 750,000 | $5,378,000 | 0.36% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,175,000 | 0.31% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,203,592 | $8,449,000 | 0.30% |
AlphaCentric Advisors LLC | 137,000 | $962,000 | 0.28% |
PFM Health Sciences, LP | 1,088,566 | $7,642,000 | 0.26% |